文献速递生殖医学

PRSS55 是男性不育的新型潜在致病基因

PRSS55 is a novel potential causative gene for human male infertility.
PubMed 文献 · Reprod Biomed Online · 2022-05-29

研究通过全外显子测序在一例畸形精子症不育男性中鉴定出 PRSS55 纯合新突变(c.575C>T [p.A192V]),经形态学、免疫荧光和蛋白印迹证实该突变改变 PRSS55 构象并致其蛋白浓度急剧下降;该例患者经卵胞浆内单精子注射助孕有效,首次提示 PRSS55 在人类生育中的关键作用。

要点

  • 在一例畸形精子症不育男性中检出 PRSS55 纯合新突变 c.575C>T(p.A192V)。
  • 该突变改变 PRSS55 构象,并使其在精子中蛋白浓度急剧下降。
  • 该例患者经卵胞浆内单精子注射治疗显示有效。

核心结论

  • 在一例不育患者中发现 PRSS55 新突变,首次提示 PRSS55 在人类生育中具有关键作用。
  • 该研究为男性不育的遗传咨询诊断及后续治疗提供了新思路。

研究设计与样本

  • 采用全外显子测序鉴定一例畸形精子症不育男性的遗传病因。
  • 用巴氏染色、扫描电镜和透射电镜探究患者精子的形态缺陷。
  • 用免疫荧光染色和蛋白印迹分析评估所鉴定突变的致病性。
  • 采用卵胞浆内单精子注射辅助该患者受精。

主要发现

  • 家系 Sanger 测序显示该不育男性携带 PRSS55 新纯合突变 c.575C>T(p.A192V)。
  • 巴氏染色、扫描电镜和透射电镜显示精子头部、颈部、中段和尾部存在形态缺陷。
  • 免疫荧光染色和蛋白印迹显示该点突变改变 PRSS55 构象,并使其蛋白浓度急剧下降。
  • 在小鼠和人类睾丸及精子中,PRSS55 表达于精细胞和附睾精子的头部与鞭毛。
  • 对该类不育患者的卵胞浆内单精子注射治疗显示有效。

临床怎么用

  • 作者认为该研究为男性不育的遗传咨询诊断及后续治疗提供了新思路。
  • 该例畸形精子症不育患者经卵胞浆内单精子注射治疗显示有效。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Testis-specific PRSS55 is a chymotrypsin-like serine protease that is highly conserved among mammalian species. The essential role of Prss55 in mouse male fertility has been established. What is the role of PRSS55 in human reproduction? DESIGN: Whole exome sequencing was used to identify the genetic cause in an infertile male with teratozoospermia. Papanicolaou staining, scanning electron microscopy (SEM) and transmission electron microscopy (TEM) were used to explore morphological defects in the patient's spermatozoa. Immunofluorescence staining and western blot analysis were conducted to assess the pathogenicity of the identified variant. Intracytoplasmic sperm injection (ICSI) was used to assist the patient with fertilization. RESULTS: Sanger sequencing of the pedigree demonstrated that the infertile man carried a novel homozygous mutation in PRSS55 (c.575C>T [p.A192V]). Morphological defects in the sperm head, neck, midpiece and tail were demonstrated by Papanicolaou staining, SEM and TEM. Immunofluorescence staining and western blotting of the patient's spermatozoa showed that the point mutation changed the conformation of PRSS55 and caused a sharp decrease in the PRSS55 protein concentration. The expression and subcellular localization of PRSS55 in the testis and spermatozoa of mice and humans showed that PRSS55 was expressed in the head and flagella of spermatids and epididymal spermatozoa. Moreover, ICSI treatment for this kind of infertile patient was shown to be effective. CONCLUSIONS: These findings revealed a novel mutation in PRSS55 in an infertile patient, suggesting for the first time the crucial role of PRSS55 in human fertility. This study provides new insight into genetic counselling diagnoses and subsequent treatment for male infertility.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Liu M, Jiang C, Zhang X, et al. PRSS55 is a novel potential causative gene for human male infertility. Reprod Biomed Online. 2022. PMID: 35821214. doi:10.1016/j.rbmo.2022.05.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。